TLR9 expanded stem-like androgen-independent prostate cancer cells through NF-κB and STAT3 activation, which in turn upregulated the expression of stemness-associated genes, including NKX3.1, KLF-4, BMI-1, and COL1A1 [153]. This evidence concerns the gene TLR9 and prostate carcinoma.